Atezolizumab/Bevacizumab
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Pharmacovigilance and Adverse Drug Reactions
Hepatocellular Carcinoma Treatment and Prognosis
Publication details
- Journal / source
- Reactions Weekly
- Volume
- 2099
- Issue
- 1
- Pages
- 24–24
- Publication date
- 26 February 2026
- Language
- EN